Widespread pain and low widespread pain index scores among fibromyalgia-positive cases assessed with the 2010/2011 fibromyalgia criteria

Journal of Rheumatology

Volumn 43, Issue 9, 2016, Pages 1743-1748

  Wolfe, Frederick ^a   Egloff, Niklaus ^b,c   Häuser, Winfried ^d,e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d KLINIKUM SAARBRÜCKEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Criteria; Fibromyalgia; Widespread pain

Indexed keywords

ADULT; ARTICLE; EPIDEMIOLOGICAL DATA; FEMALE; FIBROMYALGIA; HUMAN; LONGITUDINAL STUDY; LOW BACK PAIN; LOW WIDESPREAD PAIN INDEX SCORE; MAJOR CLINICAL STUDY; MALE; NECK PAIN; PAIN ASSESSMENT; PAIN INTENSITY; PAIN SEVERITY; PATIENT SATISFACTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SYMPTOM SEVERITY SCALE; WIDESPREAD PAIN INDEX SCORE; AGED; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84985038315     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.160153     Document Type: Article

References (20)

1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010;62:600-10.
2. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 2011;38:1113-22.
3. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
4. Egloff N, von Kanel R, Muller V, Egle UT, Kokinogenis G, Lederbogen S, et al. Implications of proposed fibromyalgia criteria across other functional pain syndromes. Scand J Rheumatol 2015;44:416-24.
5. McBeth J, Mulvey MR. Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol 2012;8:108-16.
6. Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 2013;65:777-85.
7. Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol 2007;34:1674-83.
8. Wolfe F, Michaud K. The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology 2011;50:16-24.
9. Littlejohn GO, Guymer EK. In clinical practice, the term "central sensitivity score" is more useful than the term "polysymptomatic distress scale": comment on the editorial by Wolfe. Arthritis Rheumatol 2015;67:2553.
10. Mansfield KE, Sim J, Jordan JL, Jordan KP. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain 2016;157:55-64.
11. Wolfe F. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease. J Rheumatol 2003;30:369-78.
12. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
13. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
14. Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 2009;50:613-21.
15. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258-66.
16. Stata. Stata statistical software: release 14.0. College Station: Stata Corporation; 2015.
17. Hauser W, Jung E, Erbsloh-Moller B, Gesmann M, Kuhn-Becker H, Petermann F, et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One 2012;7:e37504.
18. Kim SM, Lee SH, Kim HR. Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain 2012;25:173-82.
19. Carrillo-de-la-Pena MT, Trinanes Y, Gonzalez-Villar A, Romero-Yuste S, Gomez-Perretta C, Arias M, et al. Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ). Rheumatol Int 2015;35:141-51.
20. Jones GT, Atzeni F, Beasley M, Flus E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 2015;67:568-75.